MEI Pharma’s $100M Litecoin purchase fuels a 100% stock surge, marking a groundbreaking move in crypto treasury strategy.

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

In a bold move that’s redefining crypto’s relationship with traditional finance, MEI Pharma, a Nasdaq-listed company known ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.

MEI Pharma has become the first publicly traded company to adopt Litecoin (LTC) as a primary treasury reserve asset.

MEI Pharma, Inc. (NASDAQ:MEIP) is one of the hot penny stocks to invest in now. On July 18, MEI Pharma, Inc. (NASDAQ:MEIP) ...

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

Charlie Lee and GSR acted as lead investors, alongside participation from the Litecoin Foundation and prominent crypto ...

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group ...